Fatty liver-based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia

被引:7
作者
Brouwers, Martijn C. G. J.
van Greevenbroek, Marleen M. J.
Bilderbeek-Beckers, Monique A. L.
Robertus-Teunissen, Margee G.
van der Kallen, Carla J. H.
Stehouwer, Coen D. A.
de Bruin, Tjerk W. A.
机构
[1] Univ Hosp, Dept Med, Lab Mol Metab & Endocrinol, NL-6200 MD Maastricht, Netherlands
[2] Univ Maastricht, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands
[3] VieCuri Med Ctr, Dept Radiol, NL-5912 BL Venlo, Netherlands
[4] GlaxoSmithKline Inc, Res Triangle Pk, NC 27713 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2007年 / 56卷 / 10期
关键词
D O I
10.1016/j.metabol.2007.05.023
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The present study was conducted to investigate whether the fatty liver phenotype could be helpful in the identification of subgroups with distinct metabolic properties and lipid profiles within familial combined hyperlipidemia (FCHL). One hundred eighty-five FCHL family members participated in the current study; 38 subjects were found to be hypertriglyceridemic, of whom 66% showed evidence of fatty liver as measured with ultrasound. A detailed comparison between the hypertriglyceridemic FCHL subjects with (n = 25) and without (n = 13) fatty liver revealed that, despite very similar plasma triglyceride levels (3.5 vs 3.2 mmol/L in subjects with and without fatty liver, respectively), the fatty liver subgroup presented with significantly higher body mass index, visceral adipose tissue (ultrasound), insulin, and alanine aminotransferase levels. Moreover, very low-density lipoprotein (VLDL) subclass analysis showed that the VLDL2 fraction of the fatty liver subgroup contained significantly less cholesterol and triglycerides (P =.02 for both parameters), which was likely explained by a decreased VLDL2 particle number because VLDL2 apolipoprotein B levels tended to be lower (P =.08). These data indicate that hypertriglyceridemic FCHL subjects may belong to metabolically distinct subgroups and suggest that a refinement of the hypertriglyceridemic FCHL phenotype by adding information on fatty liver will eventually facilitate the elucidation of its complex genetic background. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1311 / 1317
页数:7
相关论文
共 32 条
[1]
ADIELS M, 2006, DIABETOLOGIA, V4, P1
[2]
Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia [J].
Aitman, TJ ;
Godsland, IF ;
Farren, B ;
Crook, D ;
Wong, HJ ;
Scott, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) :748-754
[3]
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study [J].
Austin, MA ;
McKnight, B ;
Edwards, KL ;
Bradley, CM ;
McNeely, MJ ;
Psaty, BM ;
Brunzell, JD ;
Motulsky, AC .
CIRCULATION, 2000, 101 (24) :2777-2782
[4]
Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined Hyperlipidemia [J].
Ayyobi, AF ;
McGladdery, SH ;
McNeely, MJ ;
Austin, MA ;
Motulsky, AG ;
Brunzell, JD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1289-1294
[5]
Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids [J].
Brouwers, Martijn C. G. J. ;
Bilderbeek-Beckers, Monique A. L. ;
Georgieva, Anna M. ;
van der Kallen, Carla J. H. ;
van Greevenbroek, Marleen M. J. ;
de Bruin, Tjerk W. A. .
CLINICAL SCIENCE, 2007, 112 (1-2) :123-130
[6]
Heritability and genetic loci of fatty liver in familial combined hyperlipidemia [J].
Brouwers, Martijn C. G. J. ;
Cantor, Rita M. ;
Kono, Naoko ;
Yoon, Jeong Lim ;
van der Kallen, Carla J. H. ;
Bilderbeek-Beckers, Monique A. L. ;
van Greevenbroek, Marleen M. J. ;
Lusis, Aldons J. ;
de Bruin, Tjerk W. A. .
JOURNAL OF LIPID RESEARCH, 2006, 47 (12) :2799-2807
[7]
IMPAIRED CHYLOMICRON REMNANT CLEARANCE IN FAMILIAL COMBINED HYPERLIPIDEMIA [J].
CABEZAS, MC ;
DEBRUIN, TWA ;
JANSEN, H ;
KOCK, LAW ;
KORTLANDT, W ;
ERKELENS, DW .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (06) :804-814
[9]
Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia [J].
de Bruin, TWA ;
Georgieva, AM ;
Brouwers, MCGJ ;
Heitink, MV ;
van der Kallen, CJH ;
van Greevenbroek, MMJ .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (12) :847-849
[10]
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134